A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.
source https://www.sciencedaily.com/releases/2020/12/201209115232.htm
Thursday, 10 December 2020
Related Posts
Unravelling the mystery of brown dwarfs
Breakthrough in sizing nanoparticles using fluid-filled tubes
Old habit-controlling neurons may also help the brain learn new tricks
Observing a higher-dimensional topological state with metamaterials
Carbon neutrality – a new policy brief for municipalities world wide
Climate change challenge: Terminology used by scientists confounds public
0 comments: